SK/IK (Micro regulation, calcium as regulator and will not inactivate at negative membrane potential), BK (Voltage-dependent, absent in hyperpolarization)
KCa
Couple changes in calcium to hyperpolarization
SK3/IK
SK abundant in endothelia
TRAM-34, TRAM-39
Abolish IK potassium current
TRAM-34, TRAM-39 + SK3 Inhibitor
Block NO
NS309
Lower calcium
Deletion of IK/SK3 genes
Impaired hyperpolarization
Doxycycline
Lowers potassium
Overexpression of SK3
Increases potassium
Acetylcholine, bradykinin, substance P (Agonists)
Release calcium into cytosol, induce synthesis of EDHF
Acetylcholine
Stimulates NO synthase, NON-EDHF vasodilation, elevates calcium
Bradykinin
Intracellular calcium release, NO synthase stimulation, NON-EDHF vasodilation
Substance P
Calcium influx
Elevated intracellular calcium, EDHF synthesis
Stimulate KCa, calcium-induced opening of SK/IK for endothelial hyperpolarization
SK/IK
Potassium efflux, muscle contraction
EDHF
Could be potassium
EDHF-SK/IK vasodilation
Inhibited by NO
NS309 (IK activator)
Hyperpolarization
Protein kinase C (requires calmodulin)
SK inhibition by reducing calcium sensitivity
Degree of endothelial dysfunction
Ability to dilate or constrict in response to drug